 BEIJING, June 04, 2021 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, NASDAQ: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of 16 research results at the 2021 American Society of Clinical Oncology ASCO Annual Meeting. 